Yipinhong Pharmaceutical Co Ltd Class A (300723) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, Yipinhong Pharmaceutical Co Ltd Class A (300723) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥14.81 Million ≈ $2.17 Million USD) by net assets (CN¥1.80 Billion ≈ $263.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Yipinhong Pharmaceutical Co Ltd Class A market cap and net worth for the company's overall valuation and market capitalisation.

Yipinhong Pharmaceutical Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Yipinhong Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Yipinhong Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yipinhong Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency. Explore Yipinhong Pharmaceutical Co Ltd Class A (300723) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Zhejiang DunAn Artificial Environment Co Ltd SHE:002011	0.061x
Verallia PA:VRLA	0.210x
Calumet Specialty Products Partners NASDAQ:CLMT	-0.223x
BRP Inc. NASDAQ:DOO	0.606x
Banco do Nordeste do Brasil S.A SA:BNBR3	-0.200x
Shandong Linglong Tyre Co Ltd SHG:601966	0.059x
Vietnam Airlines JSC VN:HVN	-0.690x
Trinity Industries Inc NYSE:TRN	0.060x

Annual Cash Flow Conversion Efficiency for Yipinhong Pharmaceutical Co Ltd Class A (2013–2025)

The table below shows the annual cash flow conversion efficiency of Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025. View 300723 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.41 Billion ≈ $205.84 Million	CN¥46.01 Million ≈ $6.73 Million	0.033x	+111.50%
2024-12-31	CN¥1.94 Billion ≈ $283.28 Million	CN¥-550.42 Million ≈ $-80.54 Million	-0.284x	-261.26%
2023-12-31	CN¥2.60 Billion ≈ $380.16 Million	CN¥458.05 Million ≈ $67.03 Million	0.176x	-19.70%
2022-12-31	CN¥2.17 Billion ≈ $316.92 Million	CN¥475.53 Million ≈ $69.59 Million	0.220x	+1.16%
2021-12-31	CN¥2.02 Billion ≈ $295.35 Million	CN¥438.10 Million ≈ $64.11 Million	0.217x	+17.91%
2020-12-31	CN¥1.50 Billion ≈ $218.77 Million	CN¥275.22 Million ≈ $40.27 Million	0.184x	-12.06%
2019-12-31	CN¥1.34 Billion ≈ $196.17 Million	CN¥280.65 Million ≈ $41.07 Million	0.209x	+14.00%
2018-12-31	CN¥1.30 Billion ≈ $190.13 Million	CN¥238.60 Million ≈ $34.91 Million	0.184x	+44.01%
2017-12-31	CN¥1.11 Billion ≈ $162.20 Million	CN¥141.35 Million ≈ $20.68 Million	0.128x	-70.61%
2016-12-31	CN¥336.50 Million ≈ $49.24 Million	CN¥146.01 Million ≈ $21.37 Million	0.434x	+152.00%
2015-12-31	CN¥200.66 Million ≈ $29.36 Million	CN¥34.55 Million ≈ $5.06 Million	0.172x	+151.17%
2014-12-31	CN¥127.52 Million ≈ $18.66 Million	CN¥8.74 Million ≈ $1.28 Million	0.069x	-90.62%
2013-12-31	CN¥185.61 Million ≈ $27.16 Million	CN¥135.68 Million ≈ $19.85 Million	0.731x	--

About Yipinhong Pharmaceutical Co Ltd Class A

SHE:300723 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.23 Billion

CN¥15.25 Billion CNY

Market Cap Rank

#5813 Global

#1098 in China

Share Price

CN¥33.77

Change (1 day)

-0.68%

52-Week Range

CN¥29.56 - CN¥61.82

All Time High

CN¥80.53